New research uses 3D imaging to improve the lives of lung disease patients

March 23, 2012
Research uses 3D imaging to improve the lives of lung disease patients
The amount of drug deposited in the lung after inhaling from a typical clinical nebulizer.

Pioneering research in Southampton, using hi-tech 3D imaging, could improve the lives of those suffering from chronic lung disease.

The research, led by Joy Conway, Professor of Sciences at the University of Southampton, aims to provide a better understanding of diseases such as , cystic fibrosis and asthma.

The , using a gamma camera and CAT scanner, 'map' the disease as well as how inhaled drugs specifically work within a patient's lungs. This unique 'map' is plotted by combining the data from these two pieces of specialist medical equipment.

from the University then interpret the data collected from the scans of volunteer patients to develop a distinct 360º image of how a particular drug is inhaled, dispersed and exhaled from the lungs.

The image is used to inform experts on how best to optimise the administration and delivery of inhaled drugs such as antibiotics and antivirals for diseases like asthma, but also future gene therapies for diseases such as .

It is hoped these images will also assist physiotherapists in the future, helping to improve the effectiveness of chest physiotherapy required by many patients as part of a daily routine to help clear secretions from the lungs.

The latest project, funded by the National Institute for Health Research (NIHR) Respiratory Biomedical Research Unit at University Hospital Southampton NHS Foundation Trust and the University of Southampton and the pharmaceutical industry, is investigating chronic obstructive pulmonary disease (COPD). It is a part of a much larger portfolio of clinical trials and computational research led by the imaging team and it is hoped that the findings will help inform patient care in the wider NHS.

Professor Conway says: "Diseases causing dysfunction in the lungs affect a significant proportion of the population.

"We hope our research will positively support the NHS in delivering the best possible treatment to these patients and ultimately improve their lives.

"We are privileged to be one of only a handful of universities with access to gamma camera equipment, which is dedicated to research purposes."

Explore further: Virtual lung models set to personalize asthma and COPD treatment

Related Stories

Recommended for you

Artificial beta cells

December 8, 2016

Researchers led by ETH Professor Martin Fussenegger at the Department of Biosystems Science and Engineering (D-BSSE) in Basel have produced artificial beta cells using a straightforward engineering approach.

Key regulator of bone development identified

December 8, 2016

Loss of a key protein leads to defects in skeletal development including reduced bone density and a shortening of the fingers and toes—a condition known as brachydactyly. The discovery was made by researchers at Penn State ...

Researchers question lifelong immunity to toxoplasmosis

December 8, 2016

Medical students are taught that once infected with Toxoplasma gondii—the "cat parasite"—then you're protected from reinfection for the rest of your life. This dogma should be questioned, argue researchers in an Opinion ...

TET proteins drive early neurogenesis

December 7, 2016

The fate of stem cells is determined by series of choices that sequentially narrow their available options until stem cells' offspring have found their station and purpose in the body. Their decisions are guided in part by ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.